Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 1 of 1212345...10...Last »

Obamacare plans’ drug spending rose faster than other plans in 2016: Express Scripts

Spending on Rx drugs for health plans created under the ACA increased in 2016 at a rate more than three times that of other commercial plans and most government-run plans managed by Express Scripts Holding.

Read More »

FDA approves carcinoid syndrome diarrhea drug

The U.S. FDA approved Lexicon Pharmaceuticals Inc.’s oral drug to treat carcinoid syndrome diarrhea, a condition that develops in patients with gastrointestinal tumors.

Read More »

FDA warns Pfizer over contaminated drugs at Kansas plant

The U.S. FDA said Pfizer’s process for manufacturing sterile injectable drugs at a plant in McPherson, Kansas was “out of control” and put patients at risk, according to a warning letter.

Read More »

UK rejects Merck’s Keytruda as initial treatment for lung cancer

Britain’s healthcare watchdog NICE, which assesses the cost effectiveness of medical treatments, has stopped short of recommending the use by the National Health Service (NHS) of Merck & Co. Inc.’s immunotherapy drug Keytruda in newly diagnosed lung cancer patients after giving the go-ahead in December 2016 for patients who had prior treatment.

Read More »

Kite’s cancer drug clears main study goal

Kite Pharma Inc.’s experimental CAR T-cell therapy was highly effective in treating aggressive non-Hodgkin’s lymphoma, meeting the main goal of a key study.

Read More »

Longer survival seen with Amgen’s Kyprolis vs Velcade in myeloma study

Patients with relapsed multiple myeloma treated with Amgen Inc.’s Kyprolis lived more than seven months longer than those who received Takeda Pharmaceutical Co.’s Velcade, according to data from a late-stage study released by Amgen.

Read More »

Accera’s Alzheimer’s drug trial fails

Nestle SA-backed Accera Inc.’s experimental Alzheimer’s drug failed a late-stage study in the pursuit of an effective treatment for the rampant mind-wasting disease.

Read More »

Exclusive: Janssen Pharmaceutical Just Came Clean on Drug Pricing Data

As the life sciences industry faces growing criticism over pricing of its drugs and services, Janssen released its first annual transparency report that highlights its pricing and marketing practices, patient access programs and costs of the company’s clinical trials.

Read More »

Troubled Cempra Slashes 67 Percent of Workforce

Antibiotic drugmaker Cempra Inc. will terminate 67 percent of its employees following the U.S. FDA’s rejection of solithromycin, an oral and intravenous drug being evaluated for the treatment of community-acquired bacterial pneumonia (CABP) in adults.

Read More »

Perrigo Cuts 750 Jobs, Sells MS Drug Royalties for $2.85 Billion and Loses CFO to Amgen

Shares of Perrigo were down more than 11 percent in premarket trading following the company’s announcement it was terminating 750 employees and divesting its multiple sclerosis drug Tysabri as part of a strategic plan to improve operations.

Read More »

Hepatocytes in the Drug Development Pipeline

Lonza is hosting a free 60-minute webinar on March 21, 2017, titled “Hepatocytes in the Drug Development Pipeline.”

Read More »

TrialScope Launches Trial Results Summaries Portal

TrialScope, the global leader in clinical trial transparency and compliance solutions, announced the launch of the Trial Results Summaries Portal. Through the publicly accessible website, clinical trial sponsors can inform and educate trial participants and the general public about trial results through a non-promotional and unbiased venue.

Read More »

Retain the services of Our Conversation Writing Services for Danger-Cost-free Published Speeches

Retain the services of Our Conversation Writing Services for Danger-Cost-free Published Speeches Can you write a presentation for any company event, an occasion, or for other types of get-togethers?

Read More »

Retain the services of Our Conversation Writing Services for Danger-Cost-free Published Speeches

Retain the services of Our Conversation Writing Services for Danger-Cost-free Published Speeches Can you write a presentation for any company event, an occasion, or for other types of get-togethers?

Read More »

Allergan’s New Eyepowerment Campaign Urges The Up To 33 Million Americans Suffering from Symptoms of Chronic Dry Eye to Take Action

“Before we had our voice, we had our eyes,” is the powerful opening message from Allergan’s new campaign to raise awareness for chronic dry eye. The campaign, titled “Eyepowerment,” aims to empower individuals who may be struggling with symptoms of chronic dry eye to talk to their doctor.

Read More »

Trump meets insurers, promises catastrophic year for Obamacare

President Donald Trump told several chief executives of large insurance companies that 2017 will be a “catastrophic” year for the Affordable Care Act as he seeks to make good on a campaign promise to repeal the measure.

Read More »

How exactly to Publish a Letter Asking for Grant Money

I’m going look here to become a history masterpapers visit this web-site teacher. I really miss training, therefore I determined to perform a modest on line teaching with complimentary online composing courses. These that web site documents aren’t confined to a particular nation or region. Each teacher is somewhat different inside her prerequisites. Writing a […]

Read More »

New drugs needed to fight priority pathogens

New antibiotics need to be developed urgently to combat 12 bacteria families, “priority pathogens” that are the greatest threats to human health, WHO says.

Read More »

La Jolla’s blood pressure drug clears key study

La Jolla Pharmaceutical Co.’s shares surged after the company said its drug to treat low blood pressure succeeded in a key trial.

Read More »

82% of U.S. Adults Have Trouble Sleeping, finds Packaged Facts report

206 million American adults struggling to get a good night’s rest seek out sleep management solutions to deal with conditions such as insomnia, sleep apnea, narcolepsy, and more.

Read More »

Page 1 of 1212345...10...Last »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

October 2017 Focus: Manufacturer of the Year, Top 50 Pharma, HBA and more!

Subscribe

Ad Right Bottom

Main Navigation